BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile

dc.date.accessioned	2020-10-21T06:44:36Z
dc.date.available	2020-10-21T06:44:36Z
dc.date.issued	2019
dc.date.issued	2019/01/24
dc.identifier.citation	Cecener G, Egeli U, Tunca B..J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
dc.identifier.uri	http://doi.org/10.1002/jbt.22286
dc.identifier.uri	https://hdl.handle.net/20.500.12619/71178
dc.description	PMID = 30672063
dc.relation.isversionof	10.1002/jbt.22286
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile
dc.type	article
dc.relation.journal	J Biochem Mol Toxicol
dc.identifier.doi	10.1002/jbt.22286
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Cecener G
dc.contributor.author	Egeli U
dc.contributor.author	Tunca B.
dc.relation.publicationcategory	Makale - Uluslararası Hakemli Dergi